Genetic disorders of surfactant protein dysfunction: when to consider and how to investigate
- PMID: 27417306
- DOI: 10.1136/archdischild-2012-303143
Genetic disorders of surfactant protein dysfunction: when to consider and how to investigate
Abstract
Genetic mutations affecting proteins required for normal surfactant protein function are a rare cause of respiratory disease. The genes identified that cause respiratory disease are surfactant protein B, surfactant protein C, ATP binding cassette number A3 and thyroid transcription factor-1. Surfactant protein dysfunction syndromes are highly variable in their onset and presentation, and are dependent on the genes involved and environmental factors. This heterogeneous group of conditions can be associated with significant morbidity and mortality. Presentation may be in a full-term neonate with acute and progressive respiratory distress with a high mortality or later in childhood or adulthood with signs and symptoms of interstitial lung disease. Genetic testing for these disorders is now available, providing a non-invasive diagnostic test. Other useful investigations include radiological imaging and lung biopsy. This review will provide an overview of the genetic and clinical features of surfactant protein dysfunction syndromes, and discuss when to suspect this diagnosis, how to investigate it and current treatment options.
Keywords: Interstitial lung disease; RDS; Surfactant; Surfactant protein dysfunction; chILD.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Similar articles
-
Ultrastructural characterization of genetic diffuse lung diseases in infants and children: a cohort study and review.Ultrastruct Pathol. 2013 Oct;37(5):356-65. doi: 10.3109/01913123.2013.811454. Ultrastruct Pathol. 2013. PMID: 24047351
-
Inherited disorders of neonatal lung diseases.Turk J Pediatr. 2004 Apr-Jun;46(2):105-14. Turk J Pediatr. 2004. PMID: 15214737 Review.
-
Genetic disorders of surfactant proteins.Neonatology. 2007;91(4):311-7. doi: 10.1159/000101347. Epub 2007 Jun 7. Neonatology. 2007. PMID: 17575475 Review.
-
NKX2-1 mutations leading to surfactant protein promoter dysregulation cause interstitial lung disease in "Brain-Lung-Thyroid Syndrome".Hum Mutat. 2010 Feb;31(2):E1146-62. doi: 10.1002/humu.21183. Hum Mutat. 2010. PMID: 20020530
-
[Genetic disorders of surfactant].Arch Pediatr. 2012 Feb;19(2):212-9. doi: 10.1016/j.arcped.2011.12.004. Epub 2012 Jan 9. Arch Pediatr. 2012. PMID: 22236549 Review. French.
Cited by
-
Interstitial lung disease in newborns.Semin Fetal Neonatal Med. 2017 Aug;22(4):227-233. doi: 10.1016/j.siny.2017.03.003. Epub 2017 Mar 28. Semin Fetal Neonatal Med. 2017. PMID: 28363760 Free PMC article. Review.
-
Pediatric Case Report on an Interstitial Lung Disease with a Novel Mutation of SFTPC Successfully Treated with Lung Transplantation.J Korean Med Sci. 2018 May 2;33(22):e159. doi: 10.3346/jkms.2018.33.e159. eCollection 2018 May 28. J Korean Med Sci. 2018. PMID: 29805340 Free PMC article.
-
The potential of antisense oligonucleotide therapies for inherited childhood lung diseases.Mol Cell Pediatr. 2018 Feb 6;5(1):3. doi: 10.1186/s40348-018-0081-6. Mol Cell Pediatr. 2018. PMID: 29411170 Free PMC article. Review.
-
A case report of inherited surfactant protein deficiency: unknown cause of diffuse infiltrative diseases in Tunisia.Tunis Med. 2022 Aug-Sep;100(8-9):652-655. Tunis Med. 2022. PMID: 36571734 Free PMC article.
-
Interstitial lung disease in infancy and early childhood: a clinicopathological primer.Eur Respir Rev. 2022 Mar 9;31(163):210251. doi: 10.1183/16000617.0251-2021. Print 2022 Mar 31. Eur Respir Rev. 2022. PMID: 35264412 Free PMC article. Review.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical